Non-arteritic anterior ischaemic optic neuropathy: A review and update

Journal of Clinical Neuroscience

Volumn 16, Issue 8, 2009, Pages 994-1000

  Kerr, Nathan M ^a   Chew, Shenton S S L ^a   Danesh Meyer, Helen V ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Anterior ischemic optic neuropathy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AMIODARONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BRIMONIDINE; CITICOLINE; CORTICOSTEROID; ESTROGEN; LEVODOPA; PHENYTOIN; PHOSPHODIESTERASE V INHIBITOR;

AGED; BLEEDING; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR RISK; CATARACT EXTRACTION; CLINICAL FEATURE; DECOMPRESSION SURGERY; DIFFERENTIAL DIAGNOSIS; GENETIC PREDISPOSITION; HUMAN; HYPOTENSION; ISCHEMIC OPTIC NEUROPATHY; NERVE SURGERY; NONHUMAN; OPERATION DURATION; OPTIC NERVE DISEASE; OPTIC NEURITIS; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; THROMBOSIS; VEIN INSUFFICIENCY;

DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OPTIC NERVE; OPTIC NEUROPATHY, ISCHEMIC; PROGNOSIS; RISK FACTORS;

EID: 67650112927     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2009.04.002     Document Type: Review

References (90)

1. Swartz N.G., Beck R.W., Savino P.J., et al. Pain in anterior ischemic optic neuropathy. J Neuroophthalmol 15 (1995) 9-10
2. Hayreh S.S., Podhajsky P.A., and Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 124 (1997) 641-647
3. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996; 114:1366-74.
4. Hayreh S.S., and Zimmerman M.B. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 115 (2008) 298-305
5. Hayreh S.S., and Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. Arch Ophthalmol 123 (2005) 1554-1562
6. Beck R.W., Savino P.J., Repka M.X., et al. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 91 (1984) 1334-1337
7. Hattenhauer M.G., Leavitt J.A., Hodge D.O., et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 123 (1997) 103-107
8. Johnson L.N., and Arnold A.C. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol 14 (1994) 38-44
9. Repka M.X., Savino P.J., Schatz N.J., et al. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 96 (1983) 478-483
10. Preechawat P., Bruce B.B., Newman N.J., et al. Anterior ischemic optic neuropathy in patients younger than 50 years. Am J Ophthalmol 144 (2007) 953-960
11. Arnold A.C. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 23 (2003) 157-163
12. Beck R.W., Servais G.E., and Hayreh S.S. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis. Ophthalmology 94 (1987) 1503-1508
13. Burde R.M. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 116 (1993) 759-764
14. Doro S., and Lessell S. Cup-disc ratio and ischemic optic neuropathy. Arch Ophthalmol 103 (1985) 1143-1144
15. Feit R.H., Tomsak R.L., and Ellenberger Jr. C. Structural factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol 98 (1984) 105-108
16. Jonas J.B., Gusek G.C., and Naumann G.O. Anterior ischemic optic neuropathy: nonarteritic form in small and giant cell arteritis in normal sized optic discs. Int Ophthalmol 12 (1988) 119-125
17. Jacobson D.M., Vierkant R.A., and Belongia E.A. Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol 115 (1997) 1403-1407
18. Guyer D.R., Miller N.R., Auer C.L., et al. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 103 (1985) 1136-1142
19. Hayreh S.S., Joos K.M., Podhajsky P.A., et al. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118 (1994) 766-780
20. Salomon O., Huna-Baron R., Kurtz S., et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 106 (1999) 739-742
21. Deramo V.A., Sergott R.C., Augsburger J.J., et al. Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients. Ophthalmology 110 (2003) 1041-1046
22. Hayreh S.S., Jonas J.B., and Zimmerman M.B. Nonarteritic anterior ischemic optic neuropathy and tobacco smoking. Ophthalmology 114 (2007) 804-809
23. Mojon D.S., Hedges III T.R., Ehrenberg B., et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 120 (2002) 601-605
24. Li J., McGwin Jr. G., Vaphiades M.S., et al. Non-arteritic anterior ischaemic optic neuropathy and presumed sleep apnoea syndrome screened by the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ). Br J Ophthalmol 91 (2007) 1524-1527
25. Bollinger K., and Lee M.S. Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Arch Ophthalmol 123 (2005) 400-401
26. Danesh-Meyer H.V., and Levin L.A. Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?. Br J Ophthalmol 91 (2007) 1551-1555
27. Margo C.E., and French D.D. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors. Am J Ophthalmol 143 (2007) 538-539
28. Gupta R., Singh S., Tang R., et al. Anterior ischemic optic neuropathy caused by interferon alpha therapy. Am J Med 112 (2002) 683-684
29. Lohmann C.P., Kroher G., Bogenrieder T., et al. Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma. Lancet 353 (1999) 1326
30. Lam B, Jabaly-Habib H, Al-Sheikh N, et al. Risk of nonarteritic anterior ischemic optic neuropathy after cataract extraction in the fellow eye of patients with prior unilateral nonarteritic anterior ischemic optic neuropathy. Br J Ophthalmol. 2007;91:585-7.
31. Carroll F.D. Optic nerve complications of cataract extraction. Trans Am Acad Ophthalmol Otolaryngol 77 (1973) 623-629
32. Nguyen L.T., Taravella M.J., and Pelak V.S. Determining whether delayed nonarteritic ischemic optic neuropathy associated with cataract extraction is a true entity. J Cataract Refract Surg 32 (2006) 2105-2109
33. Berggren L., Thorburn W., and Fodstad H. Three cases of non-inflammatory ischemic optic neuropathy occurring in the same family. Acta Ophthalmol (Copenh). 52 (1974) 589-595
34. Fingert J.H., Grassi M.A., Janutka J.C., et al. Mitochondrial variant G4132A is associated with familial non-arteritic anterior ischemic optic neuropathy in one large pedigree. Ophthalmic Genet 28 (2007) 1-7
35. Manor R.S. Nonarteritic ischemic optic neuropathy in identical female twins: improvement of visual outcome in one by optic nerve decompression. Arch Ophthalmol 108 (1990) 1067-1068
36. Wang M.Y., Sadun F., Levin L.B., et al. Occurrence of familial nonarteritic anterior ischemic optic neuropathy in a case series. J Neuroophthalmol 19 (1999) 144-147
37. Bosley T.M., Abu-Amero K.K., and Ozand P.T. Mitochondrial DNA nucleotide changes in non-arteritic ischemic optic neuropathy. Neurology 63 (2004) 1305-1308
38. Johns D.R., and Berman J. Alternative, simultaneous complex I mitochondrial DNA mutations in Leber's hereditary optic neuropathy. Biochem Biophys Res Commun 174 (1991) 1324-1330
39. Salomon O., Rosenberg N., Steinberg D.M., et al. Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein Ibalpha gene. Ophthalmology 111 (2004) 184-188
40. Pinna A., Solinas G., Masia C., et al. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in nonarteritic anterior ischemic optic neuropathy in a Sardinian population, Italy. Invest Ophthalmol Vis Sci 49 (2008) 1328-1332
41. Johnson L.N., Kuo H.C., and Arnold A.C. HLA-A29 as a potential risk factor for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 115 (1993) 540-542
42. Acheson J.F., and Sanders M.D. Coagulation abnormalities in ischaemic optic neuropathy. Eye 8 (1994) 89-92
43. Biousse V., Kerrison J.B., and Newman N.J. Is non-arteritic anterior ischaemic optic neuropathy related to homocysteine?. Br J Ophthalmol 84 (2000) 555
44. Kawasaki A., Purvin V.A., and Burgett R.A. Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 83 (1999) 1287-1290
45. Pianka P., Almog Y., Man O., et al. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology 107 (2000) 1588-1592
46. Weger M., Stanger O., Deutschmann H., et al. Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. Br J Ophthalmol 85 (2001) 803-806
47. Worrall B.B., Moazami G., Odel J.G., et al. Anterior ischemic optic neuropathy and activated protein C resistance. A case report and review of the literature. J Neuroophthalmol 17 (1997) 162-165
48. Knox D.L., Kerrison J.B., and Green W.R. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc 98 (2000) 203-220 discussion 21-2
49. Flaharty P.M., Sergott R.C., Lieb W., et al. Optic nerve sheath decompression may improve blood flow in anterior ischemic optic neuropathy. Ophthalmology 100 (1993) 297-302
50. Arnold A.C., and Hepler R.S. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 117 (1994) 222-230
51. Oto S., Yilmaz G., Cakmakci S., et al. Indocyanine green and fluorescein angiography in nonarteritic anterior ischemic optic neuropathy. Retina 22 (2002) 187-191
52. Levin L.A., and Louhab A. Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy. Arch Ophthalmol 114 (1996) 488-491
53. Hayreh S.S., Zimmerman M.B., Podhajsky P., et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117 (1994) 603-624
54. Hayreh S.S., Piegors D.J., and Heistad D.D. Serotonin-induced constriction of ocular arteries in atherosclerotic monkeys. Implications for ischemic disorders of the retina and optic nerve head. Arch Ophthalmol 115 (1997) 220-228
55. Levin L.A., and Danesh-Meyer H.V. Hypothesis: A venous origin for non-arteritic ischaemic optic neuropathy. Arch Ophthalmol 126 (2008) 1582-1585
56. Landau K., Winterkorn J.M., Mailloux L.U., et al. 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 114 (1996) 570-575
57. Riva C.E., Hero M., Titze P., et al. Autoregulation of human optic nerve head blood flow in response to acute changes in ocular perfusion pressure. Graefes Arch Clin Exp Ophthalmol 235 (1997) 618-626
58. Rader J., Feuer W.J., and Anderson D.R. Peripapillary vasoconstriction in the glaucomas and the anterior ischemic optic neuropathies. Am J Ophthalmol 117 (1994) 72-80
59. Strenn K., Matulla B., Wolzt M., et al. Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans. Clin Pharmacol Ther 63 (1998) 54-63
60. Tesser R.A., Niendorf E.R., and Levin L.A. The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology 110 (2003) 2031-2035
61. Rother J., Waggie K., van Bruggen N., et al. Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging. J Cereb Blood Flow Metab 16 (1996) 1353-1361
62. Ebisu T., Naruse S., Horikawa Y., et al. Discrimination between different types of white matter edema with diffusion-weighted MR imaging. J Magn Reson Imaging 3 (1993) 863-868
63. Aiello P.D., Trautmann J.C., McPhee T.J., et al. Visual prognosis in giant cell arteritis. Ophthalmology 100 (1993) 550-555
64. Liu G.T., Glaser J.S., Schatz N.J., et al. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 101 (1994) 1779-1785
65. Danesh-Meyer H., Savino P.J., and Gamble G.G. Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology 112 (2005) 1098-1103
66. Macaluso D.C., Shults W.T., and Fraunfelder F.T. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol 127 (1999) 610-612
67. Purvin V., Kawasaki A., and Borruat F.X. Optic neuropathy in patients using amiodarone. Arch Ophthalmol 124 (2006) 696-701
68. Mansour A.M., Puklin J.E., and O'Grady R. Optic nerve ultrastructure following amiodarone therapy. J Clin Neuroophthalmol 8 (1988) 231-237
69. Rizzo III J.F., Andreoli C.M., and Rabinov J.D. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 109 (2002) 1679-1684
70. Argyropoulou M.I., Zikou A.K., Tzovara I., et al. Non-arteritic anterior ischaemic optic neuropathy: evaluation of the brain and optic pathway by conventional MRI and magnetisation transfer imaging. Eur Radiol 17 (2007) 1669-1674
71. Tormene A.P., Doro D., Mantovani E., et al. Electrophysiological findings in anterior ischemic optic neuropathy. Metab Pediatr Syst Ophthalmol 12 (1989) 76-79
72. Atilla H., Tekeli O., Ornek K., et al. Pattern electroretinography and visual evoked potentials in optic nerve diseases. J Clin Neurosci 13 (2006) 55-59
73. Levin L.A. Lessons from the ischemic optic neuropathy decompression trial: a decade later. Arch Ophthalmol 125 (2007) 1570-1571
74. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA. 1995; 273:625-32.
75. Soheilian M., Koochek A., Yazdani S., et al. Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy. Retina 23 (2003) 692-697
76. Soheilian M., Yazdani S., Alizadeh-Ghavidel L., et al. Surgery for optic neuropathy. Ophthalmology 115 (2008) 1099
77. Arnold A.C., and Levin L.A. Treatment of ischemic optic neuropathy. Semin Ophthalmol 17 (2002) 39-46
78. Danylkova N.O., Alcala S.R., Pomeranz H.D., et al. Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy. Exp Eye Res 84 (2007) 293-301
79. Fazzone H.E., Kupersmith M.J., and Leibmann J. Does topical brimonidine tartrate help NAION?. Br J Ophthalmol 87 (2003) 1193-1194
80. Wilhelm B., Ludtke H., and Wilhelm H. Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol 244 (2006) 551-558
81. Yoles E., Wheeler L.A., and Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 40 (1999) 65-73
82. Bernstein S.L., Mehrabyan Z., Guo Y., et al. Estrogen is not neuroprotective in a rodent model of optic nerve stroke. Mol Vis 13 (2007) 1920-1925
83. Parisi V., Coppola G., Ziccardi L., et al. Cytidine-5'-diphosphocholine (Citicoline): a pilot study in patients with non-arteritic ischaemic optic neuropathy. Eur J Neurol 15 (2008) 465-474
84. Jung C.S., Bruce B., Newman N.J., et al. Visual function in anterior ischemic optic neuropathy: effect of Vision Restoration Therapy - a pilot study. J Neurol Sci 268 (2008) 145-149
85. Mueller I., Mast H., and Sabel B.A. Recovery of visual field defects: a large clinical observational study using vision restoration therapy. Restor Neurol Neurosci 25 (2007) 563-572
86. Danesh-Meyer H.V., Savino P.J., and Sergott R.C. The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 108 (2001) 593-598
87. Hayreh S.S., Podhajsky P.A., and Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 132 (2001) 734-742
88. Newman N.J., Scherer R., Langenberg P., et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 134 (2002) 317-328
89. Kupersmith M.J., Frohman L., Sanderson M., et al. Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol 17 (1997) 250-253
90. Beck R.W., Hayreh S.S., Podhajsky P.A., et al. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 123 (1997) 212-217